Cano, Stefan

Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods

Hobart, J., & Cano, S. (2009) · Health Technology Assessment

Psychometric Methodologies and TestingMultiple Sclerosis Research Studies

Cited by 621

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations

Hobart, J. C., Cano, S. J., Zajicek, J. P., & Thompson, A. J. (2007) · The Lancet Neurology

Psychometric Methodologies and TestingStatistical Methods in Clinical Trials

Cited by 495

Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

Powers, J. H., Patrick, D. L., Walton, M. K., Marquis, P., Cano, S., Hobart, J., Isaac, M., Vamvakas, S., Slagle, A., Molsen, E., et al. (2017) · Value in Health

Health Systems, Economic Evaluations, Quality of LifeHealth Education and Validation

Cited by 191

Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis

Bamber, L., Wang, M. Y., Prins, M. H., Ciniglio, C., Bauersachs, R., Lensing, A. W. A., & Cano, S. J. (2013) · Thrombosis and Haemostasis

Venous Thromboembolism Diagnosis and ManagementPatient Satisfaction in Healthcare

Cited by 86

The Patient and Clinician Assessment of Gastrointestinal (GI) Related Adverse Events Associated with Oral Disease-Modifying Therapies in Multiple Sclerosis: A Qualitative Study

Jivraj, F., Kang, S., Reedie, S., Kapadia, S., Strzok, S., Elliott, E., Cano, S., & Rock, M. (2022) · Advances in Therapy

Multiple Sclerosis Research StudiesPharmacovigilance and Adverse Drug Reactions

Cited by 3